Cotroneo Pat 4
4 · FIBROGEN INC · Filed Aug 11, 2020
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Controneo Pat
VP, Finance and CFO
Transactions
- Sale
Common Stock
2020-08-07$48.00/sh−22,554$1,082,592→ 271,060 total - Exercise/Conversion
Common Stock
2020-08-11$18.00/sh+3,500$63,000→ 278,310 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-11−3,500→ 0 totalExercise: $18.00Exp: 2024-11-13→ Common Stock (3,500 underlying) - Exercise/Conversion
Common Stock
2020-08-07$19.39/sh+22,554$437,322→ 293,614 total - Exercise/Conversion
Common Stock
2020-08-11$19.39/sh+3,750$72,713→ 274,810 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-07−22,554→ 9,446 totalExercise: $19.39Exp: 2026-02-22→ Common Stock (22,554 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-11−3,750→ 5,696 totalExercise: $19.39Exp: 2026-02-22→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]Fully vested.